---
title: "HASLETON MARK DANIEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/198da62c-a426-5df2-86ba-e2e971f242e5
json: https://whiteintel.dev/api/public/dossier/198da62c-a426-5df2-86ba-e2e971f242e5
identifier: sec:0001759581
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HASLETON MARK DANIEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001759581`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/198da62c-a426-5df2-86ba-e2e971f242e5  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/198da62c-a426-5df2-86ba-e2e971f242e5  

## Ownership & control

### Holdings / subsidiaries

- **ORAMED PHARMACEUTICALS INC.** (officer) — https://whiteintel.dev/entity/88a43028-7c7b-5d93-b0bb-edce2492b7dc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HASLETON MARK DANIEL**. Human view: https://whiteintel.dev/entity/198da62c-a426-5df2-86ba-e2e971f242e5 · Structured JSON: https://whiteintel.dev/api/public/dossier/198da62c-a426-5df2-86ba-e2e971f242e5._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._